CurrentCardio
Get Weekly

Topic · page 2 of 6

Cardiometabolic & kidney

Diabetes, obesity, CKD and their cardiovascular or cardiorenal outcomes, SGLT2i/GLP-1 RA outside a primary HF population

Briefs 41–80 of 238 placed here, newest publication first

Briefs in Cardiometabolic & kidney

Newest publication first

  1. J Am Coll Cardiol

    2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Guideline or statement

  2. Circulation

    2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

    Guideline or statement

  3. Eur J Prev Cardiol

    Cardiac autonomic neuropathy is associated with the incidence and progression of cardiovascular–kidney–metabolic syndrome

    Cohort study

  4. Heart

    Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes

    Research article

  5. J Am Coll Cardiol

    Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis

    Secondary analysis

  6. J Am Coll Cardiol

    Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup Analyses

    Secondary analysis

  7. JAMA Cardiol

    Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial

    Secondary analysis

  8. JACC Heart Fail

    Screening and Treatment Using a Risk-Based Approach with NT-proBNP Guidance in Diabetes Mellitus: The STRONG-DM Pilot Study

    Cohort study

  9. Eur J Prev Cardiol

    Implications of Lancet framework definition of obesity in relation to cardiovascular diseases

    Cohort study

  10. JAMA

    Six-Month Outcomes of a Trial of Potassium Supplementation Thresholds After Cardiac Surgery

    Secondary analysis

  11. Heart

    Underdiagnosis, treatment pattern and awareness of chronic kidney disease in cardiovascular disease population: results from a national observational study in China

    Cohort study

  12. Eur J Prev Cardiol

    Association of cardiometabolic disease with subclinical cardiac remodeling in men vs. women in the Framingham Heart Study

    Cross-sectional study

  13. Heart

    Abdominal adiposity and accelerated biological ageing in relation to general and cardiovascular ageing in Chinese adults

    Cohort study

  14. Eur Heart J Qual Care Clin Outcomes

    Cardiovascular and renal outcomes of GLP-1 receptor agonists in type 2 diabetes mellitus: a systematic review and meta-analysis

    Meta-analysis

  15. Eur J Heart Fail

    Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial

    Secondary analysis

  16. Circ Cardiovasc Imaging

    Assessing Left Atrial Volume Indexation to Predict Mortality in Individuals With Overweight and Obesity

    Cohort study

  17. Eur J Heart Fail

    Performance of prediction models for incident heart failure and heart failure hospitalization in individuals with type 2 diabetes: a systematic review and meta-analysis

    Meta-analysis

  18. Am Heart J

    Serial assessment of NT-proBNP and high-sensitivity cardiac troponin with glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes: Insights from EXSCEL

    Randomised controlled trial

  19. Eur J Heart Fail

    Fragility analysis of cardiovascular outcomes with finerenone in patients with Type 2 diabetes mellitus and chronic kidney disease

    Meta-analysis

  20. ESC Heart Fail

    Diet–gut microbiota interaction Index and heart failure risk in diabetes and prediabetes: evidence from NHANES 2007–2018

    Cross-sectional study

  21. JAMA Cardiol

    Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

    Secondary analysis

  22. Eur J Prev Cardiol

    Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trial

    Secondary analysis

  23. Lancet

    Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis

    Meta-analysis

  24. JACC Adv

    Systemic Inflammation and Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease

    Research article

  25. Eur J Prev Cardiol

    Associations of plant-based diets with all-cause and cause-specific mortality and life expectancy among participants with cardiometabolic disorders from UK, USA, and China

    Cohort study

  26. Eur J Prev Cardiol

    Sex-specific cardiovascular risk of lower potassium intake in patients with CKD

    Cohort study

  27. J Am Coll Cardiol

    Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus

    Cohort study

  28. Eur J Prev Cardiol

    Life-course social mobility and cardiometabolic disease: evidence from five international cohorts

    Meta-analysis

  29. Eur Heart J Cardiovasc Pharmacother

    Implementing sodium–glucose co-transporter 2 inhibitors in cardiovascular–kidney–metabolic syndrome: a multidisciplinary expert perspective

    Guideline or statement

  30. JACC Adv

    Accelerometer-Measured Sedentary Behavior, Future Disease, and Cardiovascular-Kidney-Metabolic Health

    Cohort study

  31. ESC Heart Fail

    Design, rationale, and baseline characteristics of the dapagliflozin in haemodialysis (DAPA-HD) trial

    Trial design

  32. Eur J Prev Cardiol

    Dynamic surveillance of the cardiovascular risk and identification of treatment responders in type 2 diabetes using a machine learning–based model

    Diagnostic or prognostic study

  33. Eur Heart J Qual Care Clin Outcomes

    Large-scale AI analysis reveals missed opportunities in albuminuria testing and disease-modifying therapy implementation

    Cohort study

  34. Eur Heart J Qual Care Clin Outcomes

    Sodium–glucose cotransporter 2 inhibitors across cardio-reno-metabolic disease and body mass index: a meta-analysis of randomized controlled trials

    Meta-analysis

  35. Am Heart J

    An online, predominantly plant-based, dietary intervention for improving cardiovascular risk: A randomized controlled trial in people with type 2 diabetes

    Randomised controlled trial

  36. JACC Adv

    SGLT2 Inhibitors and Mortality in Endometriosis With Type 2 Diabetes: A Propensity-Matched Analysis

    Cohort study

  37. J Am Coll Cardiol

    Chronic Kidney Disease Screening in Patients With Coronary Heart Disease: The Multinational INTERASPIRE Study

    Cohort study

  38. Eur Heart J

    Sex differences in cardiovascular–kidney–metabolic syndrome: the FINE-HEART pooled analysis

    Meta-analysis

  39. ESC Heart Fail

    Glucagon-like peptide-1 receptor agonists for prevention of heart failure events in type 2 diabetes and/or obesity

    Meta-analysis

  40. JACC Adv

    Cardiovascular-Kidney-Metabolic Syndrome and Life Expectancy in U.S. Adults

    Cohort study

All 238 Briefs in ExploreShowing Briefs 41–80 of 238, newest first